In one paragraphArticle in Clinics and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Nicoletta BernardiniDermatology Unit "Daniele Innocenzi", Department of Medical-Surgical Sciences and Biotechnologies, La Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy.ORCID 0000-0002-6295-3574 Giorgio MarottaUnit of Dermatology, Department of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00161 Rome, Italy.ORCID 0009-0007-9543-0191 Nevena SkrozaDermatology Unit "Daniele Innocenzi", Department of Medical-Surgical Sciences and Biotechnologies, La Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy.ORCID 0000-0003-4478-5404 Dario GraceffaDepartment of Clinical Dermatology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
Maria Consiglia BragazziGastroenterology Unit, Department of Medical-Surgical Sciences and Biotechnologies, La Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy.ORCID 0000-0003-3626-8546 Lucia Finistauri GuacciUnit of Dermatology, Department of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00161 Rome, Italy.
Ersilia TolinoDermatology Unit "Daniele Innocenzi", Department of Medical-Surgical Sciences and Biotechnologies, La Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy.
Francesca Paola SassoUnit of Dermatology, Department of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00161 Rome, Italy.
Umberto GalloUnit of Dermatology, Department of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00161 Rome, Italy.ORCID 0009-0008-2712-2792 Antonio Giovanni RichettaUnit of Dermatology, Department of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-8755-9178 Annunziata DattolaUnit of Dermatology, Department of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-9504-5882 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
DAPSAevery-4-week dosingguselkumabIL-23 inhibitorjoint damage progressionpsoriatic arthritisreal-world evidence
Identifiers
PMID42645142
PMCPMC13511598
What OpenQuestion holds
Textmetadata
Read underepoch 390